Abstract:Stent thrombosis (ST) at any time following percutaneous coronary intervention (PCI) is an uncommon yet life-threatening event. The true frequency of ST, particularly beyond the early weeks to months postprocedure, has been challenging to accurately quantify for a variety of reasons [1]. After the proposal and adoption of a series of formal definitions by the Academic Research Consortium (ARC) in 2007 [2], data emerged reporting frequencies of 1% for subacute ST, 0.5% for late ST, and 0.2–0.5% per year, thereafter, for very late ST (VLST) [3,4]. Independent risk factors for ST that have consistently emerged include early discontinuation of dual antiplatelet therapy (DAPT), complexity of the original PCI, and some underlying comorbidities, such as renal failure and diabetes mellitus. The reported consequences of ST are devastating with pooled data from several studies showing a composite mortality and nonfatal myocardial infarction rate of 60–80% at the time of ST or during the first week after the event [5,6]. Information regarding outcomes of ST with modern day percutaneous treatment strategies is limited. In this issue of Catheterization and Cardiovascular Interventions, Yeo et al. [7] add to the literature by reporting outcomes among 153 patients who had 165 episodes of ST within the University of California affiliate hospital network over a 5-year period (2005–2010). Data were collected retrospectively in the first half of this registry interval and prospectively thereafter using the hospital cardiac catheterization laboratory database, medical records, direct review of all angiograms, and the Social Security Death Index. Using the ARC definitions for ST, the distribution of these cases was roughly as follows: acute 4%, subacute 22%, late 18%, and very late 51%—although the exact time or interval at risk beyond 1 year was not available, and 6% of patients are not categorized or reported. As mentioned, noncompliance or premature discontinuation of DAPT is known to be associated with ST, and noteworthy in this report is that 28% of patients with subacute ST and 41% of patients with late ST were not taking DAPT. Surprisingly, nearly onethird of patients with VLST were not on either aspirin or a thienopyridine at the time of stent thrombosis. A majority of these ST cases presented with ST-segment-elevation myocardial infarction (63%), and at least half of all cases had previously received a drug-eluting stent (DES)—again data were incomplete for stent type. Novel information from this report involves procedural treatment regimens: 82% received a glycoprotein IIb/IIIa inhibitor; 52% had aspiration thrombectomy; and 61% received another stent, mainly DES. At 1-year follow-up, 18 deaths (15%) had occurred; five additional deaths occurred beyond 1 year and before study completion. These mortality rates are generally lower than previously reported. Multivariate analysis revealed that only diabetes mellitus and bifurcation disease were independently associated with an increase in in-hospital mortality. Yeo et al. describe a high proportion of VLST in their entire cohort, although this is plausible if the individual follow-up duration was long. The increasingly prevalent finding of VLST in the setting of prior DES implantation is an area whose true etiology has yet to be elucidated, and regulatory agencies are requiring very long-term follow-up information from device manufacturers. Possible mechanisms for VLST include ongoing positive arterial remodeling, late acquired incomplete stent apposition, persistent absence of endothelialization, and chronic inflammation associated with permanent polymers. Both patient-related and procedure-related characteristics have been implicated as reasons for ST, regardless of the timing. Yeo et al. describe bifurcation lesions and diabetes mellitus as the independent predictors of ST in their cohort. Likewise, the high percentage of

Time course of ethylene thiourea in maternal plasma, amniotic fluid and embryos in rats following single oral dosing.

ACUTE VASCULAR RESPONSE TO HEMODIALYSIS AS MEASURED BY SERUM SYNDECAN-1 AND ENDOTHELIN-1 LEVELS, AS WELL AS VASCULAR STIFFNESS

Oral Anticoagulation after Myocardial Infarction

Impact of Arterial Stiffness on Prognosis in Non-Diabetic Pre-Dialysis Patients with Stages 3-5 Chronic Kidney Disease

Arterial Stiffening and Clinical Outcomes in Dialysis Patients

Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patients

Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients

Association Between Arterial Stiffness and Measures of Autonomic Dysfunction in People With Chronic Kidney Disease

Characteristics of atherosclerosis in long-term survivors on maintenance hemodialysis

Clinical study on arterial stiffness in chronic kidney disease patients without dialysis

Dialysis Methods May Affect Carotid Intima–Media Thickness in Chinese End-Stage Renal Disease Patients

[Large artery wall properties in dialyse and renal transplant patients with normal blood pressure]

Arterial distensibility, intima media thickness and pulse wave velocity after renal transplantation and in dialysis normotensive patients

[Performance and prognosis assessment of the solid pseudopapillary tumors of the pancreas].

Prognostic Implication of Longitudinal Changes in Cardiothoracic Ratio and Aortic Arch Calcification in Hemodialysis Patients

Dynamics of Cardiac Autonomic Responses During Hemodialysis Measured by Heart Rate Variability and Skin Sympathetic Nerve Activity: The Impact of Interdialytic Weight Gain

Deterioration of Kidney Function Is Affected by Central Arterial Stiffness in Late Life

Cerebral blood flow pulsatility and cerebral artery stiffness acutely decrease during hemodialysis

Contemporary occurrence of stent thrombosis in clinical practice: Better never than late

Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients

Influences of changes in obesity-related parameters on progression of arteriosclerosis in hemodialysis patients: a prospective cohort study